Oxford Instruments plc issued 87,413 ordinary shares of 5 pence each during the period from 1 January to 30 April 2026, following the exercise of options and issuance under its share option plans, in a regulatory notification filed with the London Stock Exchange on 14 May 2026.
The shares were admitted to trading on the LSE Main Market using a pre-existing block admission arrangement, a standard mechanism for technology and industrial companies that operate ongoing equity-based incentive programmes requiring periodic share issuance as employees exercise options.
Following the admission of the new shares, Oxford Instruments’ total shares in issue and admitted to trading stand at 55,241,050, a modest increase that reflects the routine dilution associated with maintaining equity incentive structures across the company’s employee and management population.
The newly issued shares are fully fungible with the company’s existing ordinary shares, carry identical voting rights and entitlement to future dividends, and were treated as admitted alongside the existing share capital without any associated prospectus or further disclosure obligations given the use of the block admission framework.
Oxford Instruments operates across high-technology industrial and scientific equipment markets, supplying systems for materials characterisation, quantum technology, semiconductor processing, and life sciences research, with customers including universities, government laboratories, semiconductor manufacturers, and pharmaceutical companies.
The equity issuance sits alongside the company’s broader £50 million share buyback programme, which was announced in May 2025 and extended in March 2026, with shares repurchased under that programme either cancelled to reduce capital or transferred to treasury for use in meeting employee share plan obligations, creating an overall capital return mechanism that partially offsets the dilution from option exercise activity.
